Cargando...
Emerging drug development technologies targeting ubiquitination for cancer therapeutics
Development of effective cancer therapeutic strategies relies on our ability to interfere with cellular processes that are dysregulated in tumors. Given the essential role of the ubiquitin proteasome system (UPS) in regulating a myriad of cellular processes, it is not surprising that malfunction of...
Gardado en:
| Publicado en: | Pharmacol Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier Inc.
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7112620/ https://ncbi.nlm.nih.gov/pubmed/30851297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2019.03.003 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|